Annual Drug Patent Expirations for AGAMREE
Agamree is a drug marketed by Catalyst Pharms and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
This drug has thirty-seven patent family members in twenty countries.
The generic ingredient in AGAMREE is vamorolone. One supplier is listed for this compound. Additional details are available on the vamorolone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com